Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Sep/25/2020 Oct/19/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/22/2020 Oct/15/2020 0
Anti-SARS-CoV-2 monobody clone 6b Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020 Oct/10/2020 0
Palbociclib Potential treatment - theoretical effect Used to treat other disease Other treatment Sep/18/2020 Oct/10/2020 0
Bedoradrine Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 Oct/10/2020 0
Fimepinostat Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 Oct/10/2020 0
Darexaban Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 Oct/10/2020 0
6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 Oct/10/2020 0
4SC-202 Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 Oct/10/2020 0